TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows

Chihoko Yoshimura1, Hiromi Muraoka2, Hiroaki Ochiiwa2

  • 1Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd, Tsukuba, Japan. chihoko-yoshimura@taiho.co.jp.

Insights

TAS4464 is a potent and selective inhibitor of NEDD8-activating enzyme (NAE), a key target in cancer. This novel compound demonstrated significant antitumor activity in preclinical models, supporting its clinical evaluation for various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • The NEDD8-activating enzyme (NAE) is crucial for the neddylation pathway, regulating cancer cell proliferation and survival via cullin-RING ubiquitin ligase (CRL) complexes.
  • Targeting NAE offers a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To evaluate the preclinical profile of TAS4464, a novel, potent, and selective NAE inhibitor.
  • To compare TAS4464's efficacy against the established NAE inhibitor MLN4924.

Main Methods:

  • In vitro enzyme assays and cell-based assays to assess NAE inhibition and downstream effects.
  • Cytotoxicity profiling in various cancer cell lines and patient-derived tumor cells.
  • In vivo studies using human tumor xenograft mouse models to evaluate antitumor activity and target inhibition.

Main Results:

  • TAS4464 demonstrated high selectivity for NAE over other E1 enzymes (UAE, SAE).
  • TAS4464 effectively inhibited cullin neddylation, leading to the accumulation of CRL substrates and potent antiproliferative effects.
  • TAS4464 exhibited superior efficacy compared to MLN4924 in vitro and in vivo, with significant antitumor activity in hematologic and solid tumors without notable toxicity.

Conclusions:

  • TAS4464 represents a highly potent and selective NAE inhibitor with promising preclinical antitumor activity.
  • Its ability to achieve prolonged target inhibition and broad efficacy supports its potential as a therapeutic agent for diverse cancers.
  • Clinical evaluation of TAS4464 in both hematologic and solid tumors is warranted.

Related Concept Videos

Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
94.0K
Enzymes and Activation Energy01:13

Enzymes and Activation Energy

The activation energy (or free energy of activation), abbreviated as Ea, is the small amount of energy input necessary for all chemical reactions to occur. During chemical reactions, certain chemical bonds break, and new ones form. For example, when a glucose molecule breaks down, bonds between the molecule's carbon atoms break. Since these are energy-storing bonds, they release energy when broken. However, the molecule must be somewhat contorted to get into a state that allows the bonds to...
22.9K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.4K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.5K